Balyasny Asset Management LLC Corcept Therapeutics Inc Transaction History
Balyasny Asset Management LLC
- $61.9 Billion
- Q2 2025
A detailed history of Balyasny Asset Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Balyasny Asset Management LLC holds 47,345 shares of CORT stock, worth $3.48 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
47,345
Previous 5,064
834.93%
Holding current value
$3.48 Million
Previous $578,000
501.21%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CORT
# of Institutions
479Shares Held
83.4MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$711 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$567 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$460 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$284 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.87B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...